Skip to Main Content

Paper Details

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential.
Front Immunol
14
2021
Author NameAffiliation
Eivind HovigInstitute for Cancer Research, The Norwegian Radium Hospital
Eivind HovigUniversity of Oslo
  • 1 - 2

Datasets

Release 1.2